A critical discovery in cancer research is emerging with the use of nanobodies to reactivate dysfunctional p53. This crucial tumor protector protein is frequently inactivated in several types of cancer, causing https://thebookpage.com/story7446036/vhh-fragments-reactivate-p53-a-promising-pathway-for-cancer-therapy